Press release - Parliament to allow COVID-19 vaccines to be developed more quickly

Parliament today adopted a new Regulation by 505 votes to 67 and 109 abstentions, via the urgent procedure, that will allow COVID-19 vaccines and treatments to be developed more quickly.

Metadata

Provider:

URL:

https://www.europarl.europa.eu/news/en/press-room/20200706IPR82731/

Retrieved on:

Saturday, July 11, 2020

Information

Tags:

Branches of biology, Molecular biology, Articles, Biology, Biological engineering, Biotechnology, Vaccination, Genetically modified organism, Genetic engineering, Vaccine

Summary

Key Points:

Parliament today adopted a new Regulation by 505 votes to 67 and 109 abstentions, via the urgent procedure, that will allow COVID-19 vaccines and treatments to be developed more quickly.
Developing and deploying an effective and safe vaccine against the virus is the most likely permanent solution to stop the pandemic.
To this end, the Commission has proposed an EU vaccines strategy for COVID-19 including a temporary and strictly COVID-19-related derogation from certain rules for clinical trials.
Some COVID-19 vaccines and treatments already being developed may be defined genetically modified organisms (GMOs) and are thus covered by the relevant EU GMO Directives.